ESOPAug 3, 2026, 04:08 PM
Candel Therapeutics Grants 30,800 Stock Options to New Employees
AI Summary
Candel Therapeutics, Inc. announced that its Compensation Committee granted inducement stock options to three new employees on July 31, 2026. These options allow the purchase of an aggregate of 30,800 shares of the company's common stock at an exercise price of $10.01 per share. The awards, made under the 2025 Inducement Plan, vest 25% after one year and the remaining 75% over 36 equal monthly installments, subject to continued employment.
Key Highlights
- Candel Therapeutics granted stock options to three new employees.
- A total of 30,800 shares of common stock were granted.
- The per share exercise price for the options is $10.01.
- Options vest 25% on the first anniversary of the start date.
- The remaining 75% vests in 36 equal monthly installments thereafter.
- Awards were granted under the Company's 2025 Inducement Plan.
Price Impact
More from CADL